Filter
1136
Text search:
medicines
availability
Featured
Recommendations
132
New Publications
307
Language
Document type
No document type
588
Studies & Reports
210
Guidelines
159
Strategic & Response Plan
69
Manuals
62
Training Material
15
Fact sheets
15
Situation Updates
11
Resource Platforms
4
Infographics
2
Brochures
1
Countries / Regions
India
54
Global
53
Kenya
44
Ethiopia
30
Malawi
29
South Africa
27
Uganda
24
Africa
24
Sierra Leone
22
Nigeria
22
Tanzania
22
Liberia
20
Ghana
20
Nepal
19
Western and Central Europe
18
Rwanda
16
Myanmar / Burma
16
Zambia
15
Syria
14
Bangladesh
13
South–East Asia Region
13
Ukraine
12
Latin America and the Carribbean
12
Senegal
11
Namibia
11
Venezuela
11
Eastern Europe
10
Congo, Democratic Republic of
9
Zimbabwe
9
Philippines
9
Middle East and North Africa
8
Botswana
7
Asia
7
Guinea
6
Haiti
6
South Sudan
6
Mozambique
6
Lesotho
5
Yemen
5
East and Southern Africa
5
West and Central Africa
5
Lebanon
4
Sudan
4
Brazil
4
Russia
4
Burkina Faso
3
Côte d’Ivoire / Ivory Coast
3
Somalia
3
Pakistan
3
Cambodia
3
North Macedonia
3
Hungary
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
Mali
2
Cameroon
2
Iraq
2
Afghanistan
2
Thailand
2
Indonesia
2
Benin
2
Sri Lanka
2
Bhutan
2
Poland
2
Tajikistan
2
Moldova
2
Kyrgyzstan
2
Georgia
2
United Kingdom
2
Morocco
1
USA
1
Niger
1
Togo
1
Jordan
1
Chad
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
Eswatini/ Swaziland
1
Burundi
1
Colombia
1
Ecuador
1
Mexico
1
Other region
1
Fiji
1
Laos
1
Canada
1
Romania
1
Lithuania
1
Iran
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Jamaica
1
Mauritius
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
459
Clinical Guidelines
110
Public Health
74
Women & Child Health
54
Key Resources
48
Pharmacy & Technologies
19
Capacity Building
15
Toolboxes
HIV
97
COVID-19
83
TB
76
Mental Health
70
AMR
63
Pharmacy
43
Caregiver
33
NCDs
33
Disability
30
Conflict
30
NTDs
29
Planetary Health
22
Ebola & Marburg
20
Rapid Response
17
Refugee
12
Global Health Education
12
Natural Hazards
10
Health Financing Toolbox
9
Malaria
7
Zika
5
2.0 Rapid Response
5
Cholera
3
Polio
3
Specific Hazards
3
Typhoon
1
Social Ethics
1
The full-scale invasion of Ukraine has caused a deterioration in the level of access to health-care services and medicines in the country, particularly for people living in regions close to the front line and areas that are not partially or fully co
...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situa
...
The Ministry of Health together with its partners realizes that efficient and effective
delivery of clinical care is highly dependent on the availability of appropriately
upgraded environment, which is in well facilitated space. Such facilities an
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
The aim of these Guidelines is to provide a framework for the conservation and sustainable use of plants in medicine. To do this, the Guidelines describe the various tasks that should be carried out to ensure that where medicinal plants are taken from the wild, they are taken on a basis that is sust
...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread,
...
Food security, human health and wellbeing largely depend on biodiversity. Biodiversity supports agriculture through ecosystem services such as pollination and water purification, and provides access to natural medicines,
which are the primary sourc
...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant
...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati
...
Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained health professionals, and therapies for disease manageme
...
Available in Russian
A detailed overview is provided of the implementation of alcohol policies described in the 10 action areas of the European Action Plan to Reduce the Harmful Use of Alcohol 2012–2020 (EAPA), including the current status of implementation of the five action areas of the WHO-led
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and afford
...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin
...
Inequality of access to palliative care and symptom relief is one of the greatest disparities in global health care (1). Currently, there is avoidable suffering on a massive scale due to lack of access to palliative care and symptom relief in low- and middle-income countries (LMICs) (1). Yet basic p
...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients
...
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the neners. This new guide updates the 2006 edition
...
Since 24 February 2022, the war in Ukraine has caused widespread suffering to its people and serious damage
to the country’s infrastructure. Attacks on the country’s health system and its power network threaten people, compromise the provision of health care, and complicate the distribution of
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector
...
